Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.39%22.19M | 8.99%22.36M | -0.36%18M | 0.85%80.73M | -6.74%22.19M | -2.23%18.91M | 8.25%20.52M | 0.55%18.06M | 5.23%80.05M | 17.62%23.8M |
| Cost of revenue | 4.53%15.92M | 5.03%17.67M | -20.75%13.87M | -17.18%65.42M | -33.61%17.2M | -17.93%15.23M | -0.05%16.83M | -1.11%17.5M | -7.61%79M | 0.49%25.91M |
| Gross profit | 70.67%6.27M | 27.03%4.69M | 636.79%4.13M | 1,352.18%15.31M | 336.20%4.99M | 370.08%3.68M | 74.15%3.69M | 111.32%560K | 111.18%1.05M | 61.93%-2.11M |
| Operating expense | 33.93%5.25M | 5.37%5.11M | 0.00%4.8M | -14.37%20.34M | -93.93%1.59M | -21.17%3.92M | -7.66%4.85M | -45.46%4.8M | -26.09%23.76M | 78.77%26.16M |
| Selling and administrative expenses | 30.97%5.25M | 5.37%5.11M | 0.06%4.8M | -14.37%20.34M | -69.46%2.27M | -29.29%4.01M | 17.31%4.85M | -26.38%4.8M | -26.09%23.76M | -31.08%7.44M |
| -Selling and marketing expense | 13.53%193K | -30.09%151K | -3.03%160K | 6.36%719K | -81.39%51K | 6.92%170K | 61.19%216K | 51.38%165K | 25.42%676K | 53.07%274K |
| -General and administrative expense | 31.74%5.06M | 7.02%4.96M | 0.17%4.64M | -14.98%19.62M | -69.00%2.22M | -30.33%3.84M | 15.84%4.63M | -27.70%4.63M | -26.97%23.08M | -32.49%7.17M |
| Other operating expenses | ---- | ---- | ---- | -90.69%2.66M | -89.73%2.65M | ---- | ---- | -99.87%3K | --28.52M | --25.81M |
| Total other operating income | -97.78%2K | ---- | ---- | -51.71%3.43M | -52.97%3.34M | -87.11%90K | ---- | ---- | --7.09M | --7.09M |
| Operating profit | 519.67%1.02M | 63.95%-416K | 84.08%-675K | 77.81%-5.04M | 112.04%3.4M | 94.18%-244K | 63.11%-1.15M | 50.32%-4.24M | 45.39%-22.7M | -40.07%-28.27M |
| Net non-operating interest income (expenses) | -67.65%-285K | 7.52%-246K | 27.16%-244K | 31.43%-1.17M | 9.44%-403K | 62.96%-170K | 34.48%-266K | 16.67%-335K | 41.35%-1.71M | -15.89%-445K |
| Non-operating interest expense | 67.65%285K | -7.52%246K | -27.16%244K | -31.43%1.17M | -9.44%403K | -62.96%170K | -34.48%266K | -16.67%335K | -41.37%1.71M | 15.58%445K |
| Net investment income | 119.68%233K | -132.25%-1.18M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 111.69%2.37M | 84.07%-20.24M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -49.26%19.28M | ---- |
| Less:Other special charges | ---- | ---- | ---- | -637.07%-2.37M | ---- | ---- | ---- | ---- | 86.98%-321K | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -98.60%1.28M | ---- |
| Other non-operating income (expenses) | 2K | -99.04%2K | ||||||||
| Income before tax | 278.50%739K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 110.45%3M | 91.10%-414K | 59.82%-1.42M | 48.81%-4.58M | 72.67%-45.84M | 80.03%-28.72M |
| Income tax | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 278.02%737K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 110.45%3M | 91.10%-414K | 59.82%-1.42M | 48.81%-4.58M | 72.67%-45.84M | 80.03%-28.72M |
| Net income continuous operations | 278.02%737K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 110.45%3M | 91.10%-414K | 59.82%-1.42M | 48.81%-4.58M | 72.67%-45.84M | 80.03%-28.72M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99.54%-10K | 0 |
| Net income attributable to the company | 278.02%737K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 110.45%3M | 91.10%-414K | 59.82%-1.42M | 48.75%-4.58M | 72.31%-45.83M | 80.03%-28.72M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 278.02%737K | 53.52%-660K | 79.92%-919K | 92.12%-3.61M | 110.45%3M | 91.10%-414K | 59.82%-1.42M | 48.75%-4.58M | 72.31%-45.83M | 80.03%-28.72M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 186.36%0.001 | 53.30%-0.0009 | 79.66%-0.0012 | 92.18%-0.0046 | 110.30%0.0038 | 81.36%-0.0011 | 59.56%-0.0018 | 48.70%-0.0059 | 72.38%-0.0588 | 80.01%-0.0369 |
| Diluted earnings per share | 186.36%0.001 | 53.30%-0.0009 | 79.66%-0.0012 | 92.18%-0.0046 | 110.30%0.0038 | 81.36%-0.0011 | 59.56%-0.0018 | 48.70%-0.0059 | 72.38%-0.0588 | 80.04%-0.0369 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.